Influence of Dimethyl Sulfoxide as a Penetration Enhancer of Piroxicam Gel Through Biological Skin

Document Type: Research Paper

Authors

Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Abstract

      Piroxicam is a non-steroidal anti-inflammatory agent which has an extensive use in rheumatic disorders. Since its skin penetration is still a subject for research, the aim of this study was to evaluate the effect of dimethyl sulfoxide on percutaneous penetration of piroxicam gel formulation through skin. In this study, as a model, two types of 0.5% piroxicam new gels, so called red and green gel, were prepared using 5% (w/w) DMSO only for the red gel. Water, ethanol and propylene glycol were the solvent composition specified by a triple phase diagram, in addition to carbomer P934 and hydroxypropyl methylcellulose as the gel bases. The release and dermal penetration of the drug were measured and compared with a commercial brand using static diffusion cells and hairless rat skin as a biological membrane, by UV spec-trophotometer. Also, piroxicam serum level was measured after application of 1 g gel on the deltoid muscle, twice daily for two weeks, in three groups of healthy male volunteers. The results of all physico-chemical controls for the gels indicated an acceptable criteria. The penetration of piroxicam through animal skin showed a good linearity between the square root of time and amount of piroxicam released from the gels. The in vitro study showed that application of DMSO had no significant effect on percutaneous penetration of the drug through animal skin. In human study, the red gel containing DMSO had the highest piroxicam serum level with a relatively meaningful difference between the results compare to the green and commercial gels (pin vivo DMSO positive effect as a penetration enhancer, contrary to the in vitro results. Therefore, relying on laboratorial data is not always sufficient.

Keywords


 

1. Introduction

     Piroxicam    is    a    non-sterodial    antiinflammatory drug used in musculoskeletal and joint disorders. The most frequent adverse effects of piroxicam are reported at gastro-intestinal track, on the other hand, local irritation and bleeding may occur with piroxicam suppositories. Also there may be pain and occasionally tissue damages for the injections of piroxicam [1-4]. The gels often provide a faster release of drug substance compared to creams and ointments independent from the drug’s water solubility [5-8]. Gels effective as anti-inflammation and in musculoskeletal disorders are some recent products that are more formulated in pharmaceutical industries because of their oil free and water removable desirability, efficacy and harmless dermal effects. The most important goal of this research was measuring the permeability of piroxicam gels through the natural skin instead of a synthetic polymer. A necessary natural quality control test to make sure that a new gel has a sufficient efficacy with low toxicity before using in humans.

 

2. Materials and Methods

 

2.1.Materials

 

     Piroxicam was from Esteve Quimica, Spain, and carbomer P 934 was from B.F Goodrich, USA. Disodium editate, propylene glycol, and dimethyl sulfoxide were purchaced from Merck, Germany. Benzyl alcohol was from BDH chemicals, England, and hydroxypropyl methylcellulose from Shin-Etsu Chemical Co., Japan. Ethanol (HPMC) 96 was obtained from Parsian Co., Iran, and diisopropanolamine from Fluka Chemical, Switzland. Piroxicam, carbomer and HPMC were kindly donated by Iranian Razak , Shafa and Loghman pharmaceutical factories , respectively. All other materials were of analytical grade.

 

2.2. Preparation of the gels and pH adjustment

 

     In the first step, benzyl alcohol and disodium editate were dissolved in deionized water. Then while the solution was agitated vigorously by an electrical mixer, carbomer powder, which had been dried for one hour at 80 C previously, was added to the solution gradualy. In the second phase, 10 g of HPMC mixture was prepared by dispersion of 0.2 g HPMC in a bout 5 ml of hot (80-90 C) water, and an additional 5 g of 96% alcohols was added to the HPMC mixture and both solutions of the first and second steps were incorporated at this process. In the third stage, piroxicam powder which had been dispersed in 10 g of propylene glycol, was dissolved first by the required volume of 25% (w/w) diisopropanolamine solution and then water to a weight of 25 g. The third solution was added to the above incorporated solutions to prepare the final piroxicam gels. The red gel was different from the green gel just by replacement of 5% DMSO instead of the equivalent amount of water (Table 1). Gel formation in this formulation occurs by a chemical reaction which neutralizes the gelling agent. This pH needs to be adjusted at a range of 6.5 to 8.

 

Table 1: Formulation of piroxicam gels.

Materials

Functions

Green gel (%)

Red gel (%)

Piroxicam

Active ingredient

0.5

0.5

Carbamer 934

Jelling agent

0.6

0.6

Ethanol

Solvent

25

25

Propylene glycol

Co-solvent

10

10

Hydroxypropyl

Viscosity agent

0.2

0.2

α-methyl cellulose

 

 

 

Sodium editate

Chelating agent

0.05

0.05

Benzyl alcohol

Preservative

1

1

Dimethyl sulfoxide*

Penetration enhancer

0

5

(DMSO)

 

 

 

Di-isopropanol amine

Alkaling agent

qs to pH adjustment

qs to pH adjustment

Water

Vehicle

qs to 100

qs to 100

*Penetration enhancer


2.3. Drug content test

 

     The samples were provided by dissolving 1 g of each 5% piroxicam gel in 10 ml normal saline, separately. The blank also, was prepared with simple gel base and other inactive ingredients in normal saline. Samples containing drug were determined by a Jaco UV spectrophotometer (Japan), at 345 nm.

 

2.4. Drug permeation through animal skin

 

     Static diffusion cell (made by Jehad Daneshgahi glassware of Tehran University) was used to determine the amount of piroxicam released from the biologic skin of 95-110 g weight of female N. Mari rats. The shaved skin (Figure 1) was removed from the stomach region of the animal [6].

 

Figure 1. Shaved and excised rats.

2.5. Serum level study

 

     In other to make a comparison of DMSO influence between human and animal skin, penetration of piroxicam was studied on three groups of human (male) volunteers which their specifications are given in Table 2.

     The samples were analyzed spectrophoto-metrically following 2 weeks application of 1g gels on the deltoid muscle twice daily [7]. Ishizaki method was used to prepare blood samples [8]. In this method 0.5 mL serum was added to 0.5 mL of glacial acetic acid in a stoppered tube and incubated at 108 C for 2 h. Then 2 mL NaCl (2%) and 5 mL ethyl acetate was added to each tube and centrifugated after mixing for 20 seconds. A 4 mL sample from ethyl acetate phase was mixed to 3 mL sulfuric acid (0.1 N) for 10 seconds in another stoppered tube and centrifugated for 2 min. Finally, after aspiration of ethyl acetate part, aqueous acidic phase was measured spectrophotometrically at 354 nm.

 Table 2. The volunteer’s specifications.

 

 

 

 

.

 

 

 

Gels

Subjects No.

Age (year)

Weight (kg)

Height (cm)

 

 

MeanESD

MeanESD

MeanESD

Green

11

24.1E 1.58

74.35E5.93

175.91E3.53

Red

9

23.2E1.10

70.00E2.74

177.20E2.28

Commercial

10

24.2E1.23

73.50E3.04

178.00E2.22

2.6. Determination of preservative efficiency

 

     A suspension of the following standard strains of microorganism containing 100 millions per mL sterile sodium chloride water was prepared:

 

Asperigillus niger (ATCC no. 16404) Escherichia coli (ATCC no. 8739)

Pseudomonas aeroginosa (ATCC no. 9027)

Staphylococcus aureous (ATCC no. 6538) Candida albicans (ATCC no. 10231)

 

Turbidimetry method and counting at solid agar medium was used to identify the amount of bacteria. Samples containing 1´106  cfu/g gels were provided and incubated 24 h at 37 C  and  48  h  at  25     C  for  bacteria  and  C. albicans, respectively [9].

 

2.7. Statistical analysis of data

 

Expression of data was as mean SD and statistical analysis performed by the student “t” test or analysis of variance (ANOVA) followed by TUKEY post HOC test. Significance level was taken at (p < 0.05).

3. Results and discussion

 

3.1. Formulation criteria

 

     Applying a triple phase diagram, the most stable formulations were obtained at the ranges of 61-66, 22-27 and 8-13 g of the water phase, ethanol and propylene glycol for the solvent composition, respectively. This composition contained a bout 96 g of the gel formula and the remainder up to 100 g, was the weight of the other ingredients. The suitable pH (6.5-8) has an important role in this formulation. Not only with the view of neutralizing process of the jelling agent, but also because of the ionization of the drug molecules which decreases passing of the drug through lipid membranes [10].

     Although, the horny layer of human dermis resists pH fluctuation at 3-9. In liquid preparations such as gels the pH of liquid phase is an important factor on the activity coefficient of an acid or basic drug [11-12].

 

3.2. Viscosity

 

     The result of viscosity measurement showed that the gels containing 0.6% of carbomer P934 (jelling agent) and 0.2% of HPMC (viscosity modifier) provided the constant viscosity of 48485 and 51587.5 cps, for the red and green gels, respectively. It is important to have a constant viscosity and temperature degree during release study, because the rate of release and diffusion of drug from the vehicle base depend on the viscosity and have a reciprocal relationship, especially for the low solubility drugs.

     Carbomer P934 provides a viscosity range between 4000-6000 cps in about 0.5-0.6% concentration and also, resists heat fluctuation. This amount is generally suitable for topical gel formulations and produces the most transparency with a desirable pH value ranges of 5 to 10. The molecular weight of a drug and also vehicle polymer as the carrier, have an important and reciprocal relation ship on the molecular passing of the drug through skin [13,14].

 

3.3. Preservative efficiency

 

     The growth of microorganism in gels is a trouble phenomenon which occurs because of high percentage of water in medium. This problem may change the phisyco-chemical properties of gels such as viscosity that can affect or fluctuate the rate of surface penetration. The result of this evaluation showed a good antimicrobial activity after incubation time and the growth of the tested microorganisms were less than the reference amount (data not shown). That means applying 1% of benzyl alcohol as a microbial preservative for the gels is sufficient and therefore the efficiency of the preservative is approved qualitatively and also quantitatively.

 

3.4. Drug content

 

     The calibration curve of different concentrations of piroxicam in normal saline medium produced the standard equation of: Y=0.0444X+0.005 with R=0.9993, by which the unknown samples were calculated for their contents. The drug content of the new and commercial gels was calculated less than 5% of the labled amount. This result indicated an approved total drug and uniformity content with respect to the USP reference.

 

3.5. Rat skin penetration

 

     The release profiles of piroxicam from the green, red and RZK gel formulations through rat skin are shown in Figures 2-4, respectively. The figures show a relatively good linearity between the square root of time and amount of piroxicam release as compared with the other mechanisms (pThis result confirm that the release of piroxicam from the gel bases follows Higuchi’s equation. The results also show that there are no meaningful difference among types of the gels in release of piroxicam after 3 h (Figure 5).

 

Figure 2. The release profile of green gel through rat skin.

Figure 3. The release profile of red gel through rat skin.

Figure  4. The release profile of RZK gel through rat skin.

Figure 5. The release of piroxicam through the rat dermis after 3 h

 

3.6. Piroxicam serum level

 

     Piroxicam serum concentrations (ng/mL) in different groups of human are shown in Figure 6.

Figure 6. Piroxicam concentration in human serum.

     Human serum data show the highest level of piroxicam for the red gel with a significant difference (pp>0.05). Besides, comparing the results of piroxicam released from the gels (Figures 2-4) showed that the red gel had a better power in its release process.

 

3.7. Calculation of permeability coefficient

 

     In order to make clear and interpret the reason of a higher serum level of the red gel compared to the other gels we decided to measure the permeability coefficient of the gels applying the equation of : q=PACot [10,11]. This equation defines the terms as follows:

 

q: Amount of released drug (mg)

 

P: Permeability coefficient (cm/sec) A: Diffusion area (cm2)

 

Co: Initial concentration (mg/mL)

t: Time (sec)

 

The results are shown in Table 3.

 Table 3. Permeability coefficient of the gels.

Type of gel

Permeability coefficient (cm/sec)

Green

1.78´10 -7

Red

3.26´10 -7

RZK

1.14´10 -7

      The permeability coefficient amount of the red gel containing DMSO also, shows a significant difference (pin vitro study. This result was the same as Babar and Hsu results [6,15]. Also, it is possible that the reason of in vitro and in vivo opposite effects of DMSO as a penetration enhancer interprates by the different structure between human and rat skin, biologic medium or instrumental errors. In this study to omit instrumental influence, we decided to measure the samples by the same instrument. This method was also used by Ishizaki et al. [8] in the past years, although the authors had no other choice in the site and (or) feel not so important then it was a comparative study from a kinetic point of view.

 

Conclusion

 

     It can be concluded that from an in vitro point of view, the red and green gels are in parallel quality in comparison to the commercial gel, even though the red gel has some superiority in term of in vivo study. This preference may be related to DMSO incorporation in the red gel product as a penetration enhancer. The other conclusion is that relying on in vitro data is not always sufficient and needs to be completed by in vivo results.

[1]    Brunton LL. Goodman and Gilman’s: The phar-macological basis of therapeutics.11th ed. New York: Mc Graw-Hill, 2005; pp. 671-701.

 

[2]    Sweetman S. Martindale, 34th ed. London: Pharmaceutical Prees,2005; pp. 84.2-85.10.

 

[3]    Beringer P. Remington: The sience and practice of pharmacy. 21st ed. Philadelphia: Lippincot Williams and Wilkins, 2005; p. 1540.

 

[4]    Wickersham R M. Drug facts and comparisons. 8th ed. Missouri:Lippincott company, 2004; p. 491.

 

[5]    Olkkola KT, Brunetto AV, Mattila M I. Pharma-cokinetics of piroxicam non-strodial anti-inflammatory agents. Clin Pharmacokinet 1994; 26: 206-10.

 

[6]    Babar A, Solani UP. Piroxicam release from dermatological bases: In vitro studies using cellulose membrane and hairless mouse skin.rug Der Ind Pharm 1990;16: 523-40.

 

[7]    Fourtillan JB, Giraulty J. Piroxicam plasma concentration following repeated topical application of a piroxicam 0.5% gel. Drug Invest 1992; 4: 535-40.

 

[8]    Ishizaki T, Normura T, Abe T. Pharmacokinetics of piroxicam a new non-strodial anti-inflammatory agent under fasting and postprandial states in man. J Pharmacokinet Biopharm 1979; 7: 369-81.

 

[9]    The United States Pharmacopocia, 25th ed. Eastone, USPC Inc., 2005; pp. 1976-7.

 

[10]Swarbrick J, Lee G, Brom J. Drug permeation through human skin: Permeability of Ionizable compounds. J Pharm Sci 1984; 73:1352-5.

 

[11]Shah VP, Maibach HI. Topical drug bioavail-ability, bioeqivalence and penetration. New York: Plenum Publishing Corporation, 1993: pp. 236-57.

 

[12]Connors KA. Textbook of pharmaceutical analysis. 2nd ed. New York: Wiley-Interscience Publications, 1975; p. 49.

 

[13]Ansel HC. Introduction to pharmaceutical dosage forms. Philadelphia: Lea and Fiberger, 1985; pp. 292-5.

 

[14] Lachman L, Lieberman H A, Kanig J. The theory and practice of industrial pharmacy. 3rd ed. Philadelphia: Leo and Fiberger, 1986; pp. 534-9.

 

[15] Hsu LR, TsaiY, Huang YB. The effect of pretreament by penetration enhancers the in vivo percutaneus absorption of piroxicam from its gel form in rabbits. Inter J Pharm 1991; 71: 193-200.


 


 

 

 


Volume 2, Issue 4
Autumn 2006
Page 177-184